Clinical Trials for Pharmaceutical Development Company

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pharmaceutical Development Company

Clinical Trials (3)

NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
PHASE1/PHASE2Recruiting
72 participants
Started: May 12, 2025 · Completed: Jun 30, 2027
10 conditions1 sponsor18 locations
NCT06106672
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
PHASE1/PHASE2Recruiting
54 participants
Started: May 30, 2024 · Completed: Aug 31, 2026
4 conditions1 sponsor17 locations
NCT05104853
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Jan 25, 2022 · Completed: Jan 30, 2026
1 condition1 sponsor19 locations